Cargando…
Evaluation of Cisplatin Efficacy on HepG2 and E. coli Cells under Acidic Conditions
BACKGROUND: Cisplatin (Cispt) is a common anticancer drug for the treatment of several malignancies, including hepatocarcinoma. However, this drug suffers from instability in aqueous solutions. The study aimed to evaluate cisplatin efficacy on HepG2 and E. coli cells under an acidic condition. METHO...
Autores principales: | Babaei, Faezeh, Shahmabadi, Hasan Ebrahimi, Rajabi, Mohammad Reza, Kashani, Hamed Haddad, Izadpanah, Fatemeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825765/ https://www.ncbi.nlm.nih.gov/pubmed/30909670 http://dx.doi.org/10.31557/APJCP.2019.20.3.723 |
Ejemplares similares
-
Cisplatin-resistant HepG2 cell-derived exosomes transfer cisplatin resistance to cisplatin-sensitive cells in HCC
por: Tang, Zuxiong, et al.
Publicado: (2021) -
VX680 suppresses the growth of HepG2 cells and enhances the chemosensitivity to cisplatin
por: YAO, RUCHENG, et al.
Publicado: (2014) -
Effects of dihydroartemisinin combined with cisplatin on proliferation, apoptosis and migration of HepG2 cells
por: Rao, Qi, et al.
Publicado: (2022) -
Effects of ginkgol C17:1 on cisplatin-induced autophagy and apoptosis in HepG2 cells
por: Liu, Jun, et al.
Publicado: (2018) -
Ursolic acid sensitizes cisplatin-resistant HepG2/DDP cells to cisplatin via inhibiting Nrf2/ARE pathway
por: Wu, Shouhai, et al.
Publicado: (2016)